Alopecia causes: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(45 intermediate revisions by 10 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Alopecia}}
{{Alopecia}}
{{CMG}}
{{CMG}} [[Ogechukwu Hannah Nnabude, MD]]
==Overview==
==Overview==
Scarring alopecia is caused by numerous dermatologic factors, including glabrous skin (non-hairy), and is very difficult to diagnose and manage.  Non-scarring alopecia is characterized by the absence of visible [[inflammation]] of the [[skin]] involved.
Scarring alopecia is caused by numerous dermatologic factors, including glabrous skin (non-hairy), and is very difficult to diagnose and manage.  [[Non-scarring alopecia]] is characterized by the absence of visible [[inflammation]] of the [[skin]] involved. Endocrine abnormalities such as [[hypothyroidism]] and [[Cushing's syndrome]], medications such as [[allopurinol]], [[warfarin]] and [[steroids]], [[autoimmune diseases]] such as [[systemic lupus erythematosus]], and infectious diseases such as [[syphilis]] and [[tinea capitis]] can also cause [[alopecia]].


==Causes==
==Causes==
===Common Causes===
===Common Causes===


A sudden physical or emotional stress may cause one-half to three-quarters of the hair throughout your scalp to shed (called Telogen effluvium). You will notice hair coming out in handfuls while you shampoo, comb, or run your hands through your hair. You may not notice this for weeks to months after the episode of stress. The hair shedding will decrease over 6 - 8 months.
Severe emotional or physical stress may cause one-half to three-quarters of the hair on the scalp to shed in a type of [[alopecia]] called [[telogen effluvium]]. Shampooing, combing, or just stroking thee hair can lead to massive amounts of hair being detached from the scalp. This may occur to a noticeable degree weeks or even months after the stressful episode. The rate of hair loss often slows down after about 6 - 8 months.


Cause of this type of hair loss are:
Triggering factors may include:


* High [[fever]] or severe [[infection]]
* High [[fever]] or severe [[infection]] <ref name="pmid23974577">{{cite journal| author=Grover C, Khurana A| title=Telogen effluvium. | journal=Indian J Dermatol Venereol Leprol | year= 2013 | volume= 79 | issue= 5 | pages= 591-603 | pmid=23974577 | doi=10.4103/0378-6323.116731 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23974577  }} </ref>.
* Childbirth
* Childbirth <ref name="pmid32607303">{{cite journal| author=Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R| title=Telogen Effluvium: A Review of the Literature. | journal=Cureus | year= 2020 | volume= 12 | issue= 5 | pages= e8320 | pmid=32607303 | doi=10.7759/cureus.8320 | pmc=7320655 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32607303  }} </ref>
* Major [[surgery]], major [[illness]], sudden blood loss
* Major [[surgery]], major [[illness]], sudden blood loss <ref name="pmid32607303">{{cite journal| author=Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R| title=Telogen Effluvium: A Review of the Literature. | journal=Cureus | year= 2020 | volume= 12 | issue= 5 | pages= e8320 | pmid=32607303 | doi=10.7759/cureus.8320 | pmc=7320655 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32607303  }} </ref>
* Severe emotional stress
* Severe emotional stress <ref name="pmid32607303">{{cite journal| author=Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R| title=Telogen Effluvium: A Review of the Literature. | journal=Cureus | year= 2020 | volume= 12 | issue= 5 | pages= e8320 | pmid=32607303 | doi=10.7759/cureus.8320 | pmc=7320655 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32607303  }} </ref>
* Crash diets, especially those that do not contain enough protein
* Crash diets, especially those that do not contain enough protein <ref name="pmid28243487">{{cite journal| author=Guo EL, Katta R| title=Diet and hair loss: effects of nutrient deficiency and supplement use. | journal=Dermatol Pract Concept | year= 2017 | volume= 7 | issue= 1 | pages= 1-10 | pmid=28243487 | doi=10.5826/dpc.0701a01 | pmc=5315033 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28243487  }} </ref>
* A number of medications, including [[retinoids]], birth control pills, [[beta-blockers]], certain [[antidepressants]], [[NSAIDs]] (including [[ibuprofen]]) and [[calcium channel blockers]]
* A number of medications, including [[retinoids]], [[anticoagulants]] <ref name="pmid27747798">{{cite journal| author=Watras MM, Patel JP, Arya R| title=Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature. | journal=Drugs Real World Outcomes | year= 2016 | volume= 3 | issue= 1 | pages= 1-6 | pmid=27747798 | doi=10.1007/s40801-015-0056-z | pmc=4819463 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27747798  }} </ref>, [[beta-blockers]]<ref name="pmid3979099">{{cite journal| author=Shelley ED, Shelley WB| title=Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol. | journal=Cutis | year= 1985 | volume= 35 | issue= 2 | pages= 148-9 | pmid=3979099 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3979099  }} </ref>, certain [[antidepressants]] <ref name="pmid28763345">{{cite journal| author=Etminan M, Sodhi M, Procyshyn RM, Guo M, Carleton BC| title=Risk of hair loss with different antidepressants: a comparative retrospective cohort study. | journal=Int Clin Psychopharmacol | year= 2018 | volume= 33 | issue= 1 | pages= 44-48 | pmid=28763345 | doi=10.1097/YIC.0000000000000191 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28763345  }} </ref>, [[NSAIDs]] (including [[ibuprofen]]) and anticonvulsants <ref name="pmid29207731">{{cite journal| author=Thomson SR, Mamulpet V, Adiga S| title=Sodium Valproate Induced Alopecia: A Case Series. | journal=J Clin Diagn Res | year= 2017 | volume= 11 | issue= 9 | pages= FR01-FR02 | pmid=29207731 | doi=10.7860/JCDR/2017/28564.10658 | pmc=5713753 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29207731  }} </ref> and trimethadione. <ref name="pmid13715510">{{cite journal| author=HOLOWACH J, SANDEN HV| title=Alopecia as a side effect of treatment of epilepsy with trimethadione. Report of two cases. | journal=N Engl J Med | year= 1960 | volume= 263 | issue=  | pages= 1187 | pmid=13715510 | doi=10.1056/NEJM196012082632308 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13715510  }} </ref>


Other possible causes of hair loss, especially if it is in an unusual pattern, include:
Other possible causes of hair loss, especially if it is in an unusual pattern, include:
Line 23: Line 23:
* [[Alopecia areata]] -- bald patches that develop on the scalp, beard, and, possibly, eyebrows. Eyelashes may fall out as well.
* [[Alopecia areata]] -- bald patches that develop on the scalp, beard, and, possibly, eyebrows. Eyelashes may fall out as well.
* [[Anemia]]
* [[Anemia]]
* [[Autoimmune]] conditions such as lupus
* [[Autoimmune]] conditions such as [[systemic lupus erythematosus]]  <ref name="pmid32699719">{{cite journal| author=Forouzan P, Cohen PR| title=Systemic Lupus Erythematosus Presenting as Alopecia Areata. | journal=Cureus | year= 2020 | volume= 12 | issue= 6 | pages= e8724 | pmid=32699719 | doi=10.7759/cureus.8724 | pmc=7372242 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32699719  }} </ref>
* [[Burns]]
* [[Burns]]
* Certain infectious diseases such as [[syphilis]]
* Certain infectious diseases such as [[syphilis]]
* Excessive shampooing and blow-drying
* Excessive shampooing and blow-drying
* [[Hormone]] changes
* [[Hormone]] changes
* [[Thyroid diseases]]
* [[Thyroid diseases]] <ref name="pmid23960405">{{cite journal| author=Vincent M, Yogiraj K| title=A Descriptive Study of Alopecia Patterns and their Relation to Thyroid Dysfunction. | journal=Int J Trichology | year= 2013 | volume= 5 | issue= 1 | pages= 57-60 | pmid=23960405 | doi=10.4103/0974-7753.114701 | pmc=3746235 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23960405  }} </ref>
* Nervous habits such as continual hair pulling or scalp rubbing
* Nervous habits such as continual hair pulling or scalp rubbing
* [[Radiation therapy]]
* [[Radiation therapy]]
* [[Tinea capitis]] ([[ringworm]] of the scalp)
* [[Tinea capitis]] ([[ringworm]] of the scalp)
* [[Tumor]] of the [[ovary]] or [[adrenal glands]]
* [[Tumor]] of the [[ovary]] or [[adrenal glands]]
===Causes by Organ System===
===Causes by Organ System===
{|style="width:80%; height:100px" border="1"
{|style="width:80%; height:100px" border="1"
Line 48: Line 49:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Drug Side Effect'''
| '''Drug Side Effect'''
|bgcolor="Beige"| [[Aclarubicin]], [[actinomycin D]], [[albendazole]], [[amiodarone]], [[antidepressants]], [[beta blockers]], [[birth control pills]], [[calcium channel blockers]], [[cidofovir]], [[clomifene]], [[colchicine]], [[combined oral contraceptive pill]], [[Cyclophosphamide]],  [[Cytarabine]], [[cytosine arabinoside]], [[cytotoxic therapeutic agents]], [[danazol]], [[daunorubicin]], [[docetaxel]], [[Doxorubicin Hydrochloride]], [[eflornithine]], [[epirubicin]], [[etoposide]], [[Febuxostat]], [[fluoxymesterone]], [[gestrinone]], [[heparin]], [[hydroxychloroquine]], [[idarubicin]], [[ifosfamide]], [[interferon alpha]], [[irinotecan]], [[leflunomide]], [[melphalan]], [[mesalamine]], [[methotrexate]], [[methylphenidate]], [[minocycline hydrochloride]], [[mitoxantrone]], [[nabumetone]], [[naltrexone]], [[NSAIDs]], [[oxaliplatin]], [[oxcarbazepine]], [[pazopanib]], [[pixantrone]], [[pramipexole]], [[proguanil]], [[repaglinide]], [[retinoids]], [[sorafenib]], [[stanozolol]], [[sulindac]], [[Spironolactone]],[[teniposide]], [[teriflunomide]], [[testosterone]], [[thiotepa]], [[topotecan]], [[trabectedin]], [[Tretinoin]], [[tribavirin]], [[valproic acid]], [[vemurafenib]], [[vincristine]], [[vismodegib]]
|bgcolor="Beige"| [[Aclarubicin]], [[actinomycin D]], [[albendazole]], [[amiodarone]], [[antidepressants]], [[Aprepitant]], [[beta blockers]] <ref name="pmid3979099">{{cite journal| author=Shelley ED, Shelley WB| title=Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol. | journal=Cutis | year= 1985 | volume= 35 | issue= 2 | pages= 148-9 | pmid=3979099 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3979099  }} </ref>, [[Bicalutamide]],  [[birth control pills]], [[calcium channel blockers]], [[cidofovir]], [[clomifene]], [[colchicine]], [[combined oral contraceptive pill]], [[Cyclophosphamide]],  [[Cytarabine]], [[cytosine arabinoside]], [[cytotoxic therapeutic agents]], [[dabrafenib mesylate]], [[Dacarbazine]], [[Dactinomycin]], [[danazol]], [[daunorubicin]], [[docetaxel]], [[Doxorubicin Hydrochloride]], [[eflornithine]], [[Epirubicin hydrochloride]], [[Epirubicin ]],  [[Eribulin]], [[etoposide]], [[Febuxostat]], [[Fluorouracil]], [[Floxuridine]], [[fluoxymesterone]], [[gestrinone]], [[heparin]], [[hydroxychloroquine]], [[idarubicin]], [[ifosfamide]], [[interferon alpha]], [[Interferon alfa-2b ]],  [[irinotecan hydrochloride]], [[Ixabepilone]], [[lamivudine]], [[leflunomide]], [[Leuprolide]], [[Levoleucovorin]], [[Levobunolol hydrochloride]], [[lomustine]], [[Megestrol]], [[melphalan]], [[mesalamine]], [[methotrexate]], [[methylphenidate]], [[minocycline hydrochloride]], [[Mitomycin]], [[mitoxantrone]], [[nabumetone]], [[naltrexone]], [[NSAIDs]], [[Olsalazine]], [[Oxandrolone]], [[oxaliplatin]], [[Oxaprozin]], [[oxcarbazepine]], [[paclitaxel]], [[Palbociclib]], [[pazopanib]], [[Penicillamine]], [[Pertuzumab]], [[pixantrone]], [[pramipexole]], [[proguanil]], [[repaglinide]], [[retinoids]], [[Sargramostim]], [[Sodium aurothiomalate]], [[sorafenib]], [[stanozolol]], [[Sulfasalazine]], [[sulindac]], [[Spironolactone]], [[Temozolomide]], [[teniposide]], [[teriflunomide]], [[testosterone]], [[thiotepa]], [[Tiagabine]], [[topotecan]], [[trabectedin]], [[Tretinoin]], [[tribavirin]], [[valproic acid]], [[vemurafenib]], [[vincristine]], [[Vinblastine]], [[vismodegib]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 148: Line 149:
|}
|}


===Causes in Alphabetical Order===
===List of Causes in Alphabetical Order===
{{MultiCol}}
 
*[[Ablepharon macrostomia syndrome]]
*[[Ablepharon macrostomia syndrome]]
*[[Aclarubicin]]
*[[Aclarubicin]]
Line 164: Line 165:
*[[Anemia]]
*[[Anemia]]
*[[Antidepressants]]
*[[Antidepressants]]
*[[Aprepitant]]
*[[Atopic dermatitis]]
*[[Atopic dermatitis]]
*[[Autoimmune adrenalitis]]
*[[Autoimmune adrenalitis]]
*[[Bazex-Dupre-Christol syndrome]]
*[[Bazex-Dupre-Christol syndrome]]
*[[Beta blockers]]
*[[Beta blockers]] <ref name="pmid3979099">{{cite journal| author=Shelley ED, Shelley WB| title=Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol. | journal=Cutis | year= 1985 | volume= 35 | issue= 2 | pages= 148-9 | pmid=3979099 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3979099  }} </ref>
*[[Biotinidase deficiency]]
*[[Biotinidase deficiency]]
*[[Birth control pills]]
*[[Birth control pills]]
Line 200: Line 202:
*[[Eflornithine]]
*[[Eflornithine]]
*[[Epidermolysis bullosa]] with pyloric atresia
*[[Epidermolysis bullosa]] with pyloric atresia
*[[Epirubicin]]
*[[Epirubicin hydrochloride]]
*[[Eribulin]]
*[[Erythroderma]]
*[[Erythroderma]]
*[[Etoposide]]
*[[Etoposide]]
Line 230: Line 233:
*[[Incontinentia pigmenti]]
*[[Incontinentia pigmenti]]
*[[Interferon alpha]]
*[[Interferon alpha]]
{{ColBreak}}
*[[Irinotecan hydrochloride]]
*[[Irinotecan]]
*[[Iron deficiency]]
*[[Iron deficiency]]
*[[Ixabepilone]]
*[[Junctional epidermolysis bullosa, non-Herlitz type]]
*[[Junctional epidermolysis bullosa, non-Herlitz type]]
*[[Keratitis-ichthyosis-deafness syndrome, autosomal recessive]]
*[[Keratitis-ichthyosis-deafness syndrome, autosomal recessive]]
Line 256: Line 259:
*[[Ovarian tumor]]
*[[Ovarian tumor]]
*[[Oxaliplatin]]
*[[Oxaliplatin]]
*[[Oxaprozin]]
*[[Paclitaxel]]
*[[Palbociclib]]
*[[Papular atrichia]]
*[[Papular atrichia]]
*[[Parry-Romberg syndrome]]
*[[Parry-Romberg syndrome]]
Line 270: Line 276:
*[[Retinoids]]
*[[Retinoids]]
*[[Rosselli-Gulienetti syndrome]]
*[[Rosselli-Gulienetti syndrome]]
*[[Sargramostim]]
*[[Schopf-Schulz-Passarge syndrome]]
*[[Schopf-Schulz-Passarge syndrome]]
*[[Secondary syphilis]]
*[[Secondary syphilis]]
Line 279: Line 286:
*[[Stanozolol]]
*[[Stanozolol]]
*Sudden [[blood loss]]
*Sudden [[blood loss]]
*[[Systemic lupus erythematosus]]
*[[Systemic lupus erythematosus]] <ref name="pmid32699719">{{cite journal| author=Forouzan P, Cohen PR| title=Systemic Lupus Erythematosus Presenting as Alopecia Areata. | journal=Cureus | year= 2020 | volume= 12 | issue= 6 | pages= e8724 | pmid=32699719 | doi=10.7759/cureus.8724 | pmc=7372242 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32699719  }} </ref>, [[dermatomyositis]] <ref name="pmid10615903">{{cite journal| author=Callen JP| title=Dermatomyositis. | journal=Lancet | year= 2000 | volume= 355 | issue= 9197 | pages= 53-7 | pmid=10615903 | doi=10.1016/S0140-6736(99)05157-0 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10615903  }} </ref>
*[[Temozolomide]]
*[[Teniposide]]
*[[Teniposide]]
*[[Teriflunomide]]
*[[Teriflunomide]]
Line 286: Line 294:
*[[Thiotepa]]
*[[Thiotepa]]
*[[Thyroid diseases]]
*[[Thyroid diseases]]
*[[Tiagabine]]
*[[Tinea capitis]]
*[[Tinea capitis]]
*[[Tinea favosa capitis]]
*[[Tinea favosa capitis]]
Line 308: Line 317:
*[[Woodhouse-Sakati syndrome]]
*[[Woodhouse-Sakati syndrome]]
*[[Zinc deficiency]]
*[[Zinc deficiency]]
{{EndMultiCol}}


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Primary care]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Dermatology]]
[[Category:Dermatology]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 08:47, 25 May 2021

Alopecia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Alopecia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Laser Therapy

Concealing Hair Loss

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alopecia causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Alopecia causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alopecia causes

CDC on Alopecia causes

Alopecia causes in the news

Blogs on Alopecia causes

Directions to Hospitals Treating Alopecia

Risk calculators and risk factors for Alopecia causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ogechukwu Hannah Nnabude, MD

Overview

Scarring alopecia is caused by numerous dermatologic factors, including glabrous skin (non-hairy), and is very difficult to diagnose and manage. Non-scarring alopecia is characterized by the absence of visible inflammation of the skin involved. Endocrine abnormalities such as hypothyroidism and Cushing's syndrome, medications such as allopurinol, warfarin and steroids, autoimmune diseases such as systemic lupus erythematosus, and infectious diseases such as syphilis and tinea capitis can also cause alopecia.

Causes

Common Causes

Severe emotional or physical stress may cause one-half to three-quarters of the hair on the scalp to shed in a type of alopecia called telogen effluvium. Shampooing, combing, or just stroking thee hair can lead to massive amounts of hair being detached from the scalp. This may occur to a noticeable degree weeks or even months after the stressful episode. The rate of hair loss often slows down after about 6 - 8 months.

Triggering factors may include:

Other possible causes of hair loss, especially if it is in an unusual pattern, include:

Causes by Organ System

Cardiovascular Vasculitis
Chemical / poisoning Selenium, thallium
Dermatologic Acrokeratosis paraneoplastica of Bazex, alopecia cicatrisata, alopecia mucinosa, discoid lupus erythematosus, erythroderma, folliculitis, folliculitis decalvans, keratosis follicularis spinulosa decalvans cum op, perifolliculitis capitis abscedens et suffodiens, pseudopelade of Brocq, tufted folliculitis, Parry-Romberg syndrome
Drug Side Effect Aclarubicin, actinomycin D, albendazole, amiodarone, antidepressants, Aprepitant, beta blockers [5], Bicalutamide, birth control pills, calcium channel blockers, cidofovir, clomifene, colchicine, combined oral contraceptive pill, Cyclophosphamide, Cytarabine, cytosine arabinoside, cytotoxic therapeutic agents, dabrafenib mesylate, Dacarbazine, Dactinomycin, danazol, daunorubicin, docetaxel, Doxorubicin Hydrochloride, eflornithine, Epirubicin hydrochloride, Epirubicin , Eribulin, etoposide, Febuxostat, Fluorouracil, Floxuridine, fluoxymesterone, gestrinone, heparin, hydroxychloroquine, idarubicin, ifosfamide, interferon alpha, Interferon alfa-2b , irinotecan hydrochloride, Ixabepilone, lamivudine, leflunomide, Leuprolide, Levoleucovorin, Levobunolol hydrochloride, lomustine, Megestrol, melphalan, mesalamine, methotrexate, methylphenidate, minocycline hydrochloride, Mitomycin, mitoxantrone, nabumetone, naltrexone, NSAIDs, Olsalazine, Oxandrolone, oxaliplatin, Oxaprozin, oxcarbazepine, paclitaxel, Palbociclib, pazopanib, Penicillamine, Pertuzumab, pixantrone, pramipexole, proguanil, repaglinide, retinoids, Sargramostim, Sodium aurothiomalate, sorafenib, stanozolol, Sulfasalazine, sulindac, Spironolactone, Temozolomide, teniposide, teriflunomide, testosterone, thiotepa, Tiagabine, topotecan, trabectedin, Tretinoin, tribavirin, valproic acid, vemurafenib, vincristine, Vinblastine, vismodegib
Ear Nose Throat No underlying causes
Endocrine Adrenal cortex insufficiency, hormone changes, hyperthyroidism, hypopituitarism, hypothyroidism, thyroid diseases
Environmental No underlying causes
Gastroenterologic Canada-Cronkhite syndrome
Genetic Ablepharon macrostomia syndrome, Bazex-Dupre-Christol syndrome, biotinidase deficiency, BRESHECK syndrome, CARASIL, chondrodysplasia punctata 2, X-linked dominant, dermatopathia pigmentosa reticularis, Dubowitz syndrome, dwarfism-cerebral atrophy-keratosis follicularis syndrome, dystrophia myotonica type 2, epidermolysis bullosa with pyloric atresia, haemochromatosis, Hallermann-Streiff syndrome (HSS), Hay-Wells syndrome, hidrotic ectodermal dysplasia, holocarboxylase synthase deficiency, Hutchinson-Gilford progeria syndrome, hypohidrotic ectodermal dysplasia, autosomal dominant, hypohidrotic ectodermal dysplasia, autosomal recessive type, hypohidrotic ectodermal dysplasia, X-linked, hypotrichosis simplex, incontinentia pigmenti, junctional epidermolysis bullosa, non-Herlitz type, keratitis-ichthyosis-deafness syndrome, autosomal recessive, keratosis follicularis spinulosa decalvans cum ophiasi, lamellar ichthyosis type 2, Marie Unna hereditary hypotrichosis, monilethrix, myositis ossificans progressiva, orofaciodigital syndrome type 1, papular atrichia, proteus syndrome, pseudoprogeria syndrome, Rosselli-Gulienetti syndrome, Schopf-Schulz-Passarge syndrome, total congenital alopecia, vitamin D dependent rickets type 2a, Werner syndrome, Woodhouse-Sakati syndrome
Hematologic Anemia, sudden blood loss
Iatrogenic Major surgery, radiotherapy
Infectious Disease Chagas disease, dissecting cellulitis, lepromatous leprosy, secondary syphilis, severe infection, shingles, tinea capitis, tinea favosa capitis, tuberculoid leprosy
Musculoskeletal / Ortho Myotonic dystrophy
Neurologic Parry-Romberg syndrome
Nutritional / Metabolic Hypervitaminosis A, iron deficiency, vitamin H deficiency, zinc deficiency
Obstetric/Gynecologic Child birth, pregnancy
Oncologic Adrenal gland tumor, Cutaneous T-cell lymphoma, Ovarian tumor
Ophthalmologic No underlying causes
Overdose / Toxicity No underlying causes
Psychiatric Severe emotional stress, trichotillomania
Pulmonary No underlying causes
Renal / Electrolyte No underlying causes
Rheum / Immune / Allergy Alopecia areata, atopic dermatitis, autoimmune adrenalitis, lichen planopilaris, lichen planus, psoriasis, systemic lupus erythematosus, Vogt-Koyanagi-Harada syndrome
Sexual No underlying causes
Trauma Burns, traction alopecia
Urologic No underlying causes
Dental No underlying causes
Miscellaneous Aging, crash diet, excessive blow-drying, excessive shampooing, high fever, major illness

List of Causes in Alphabetical Order

References

  1. ↑ Grover C, Khurana A (2013). "Telogen effluvium". Indian J Dermatol Venereol Leprol. 79 (5): 591–603. doi:10.4103/0378-6323.116731. PMID 23974577.
  2. ↑ 2.0 2.1 2.2 Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R (2020). "Telogen Effluvium: A Review of the Literature". Cureus. 12 (5): e8320. doi:10.7759/cureus.8320. PMC 7320655 Check |pmc= value (help). PMID 32607303 Check |pmid= value (help).
  3. ↑ Guo EL, Katta R (2017). "Diet and hair loss: effects of nutrient deficiency and supplement use". Dermatol Pract Concept. 7 (1): 1–10. doi:10.5826/dpc.0701a01. PMC 5315033. PMID 28243487.
  4. ↑ Watras MM, Patel JP, Arya R (2016). "Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature". Drugs Real World Outcomes. 3 (1): 1–6. doi:10.1007/s40801-015-0056-z. PMC 4819463. PMID 27747798.
  5. ↑ 5.0 5.1 5.2 Shelley ED, Shelley WB (1985). "Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol". Cutis. 35 (2): 148–9. PMID 3979099.
  6. ↑ Etminan M, Sodhi M, Procyshyn RM, Guo M, Carleton BC (2018). "Risk of hair loss with different antidepressants: a comparative retrospective cohort study". Int Clin Psychopharmacol. 33 (1): 44–48. doi:10.1097/YIC.0000000000000191. PMID 28763345.
  7. ↑ Thomson SR, Mamulpet V, Adiga S (2017). "Sodium Valproate Induced Alopecia: A Case Series". J Clin Diagn Res. 11 (9): FR01–FR02. doi:10.7860/JCDR/2017/28564.10658. PMC 5713753. PMID 29207731.
  8. ↑ HOLOWACH J, SANDEN HV (1960). "Alopecia as a side effect of treatment of epilepsy with trimethadione. Report of two cases". N Engl J Med. 263: 1187. doi:10.1056/NEJM196012082632308. PMID 13715510.
  9. ↑ 9.0 9.1 Forouzan P, Cohen PR (2020). "Systemic Lupus Erythematosus Presenting as Alopecia Areata". Cureus. 12 (6): e8724. doi:10.7759/cureus.8724. PMC 7372242 Check |pmc= value (help). PMID 32699719 Check |pmid= value (help).
  10. ↑ Vincent M, Yogiraj K (2013). "A Descriptive Study of Alopecia Patterns and their Relation to Thyroid Dysfunction". Int J Trichology. 5 (1): 57–60. doi:10.4103/0974-7753.114701. PMC 3746235. PMID 23960405.
  11. ↑ Callen JP (2000). "Dermatomyositis". Lancet. 355 (9197): 53–7. doi:10.1016/S0140-6736(99)05157-0. PMID 10615903.
Retrieved from "https://www.wikidoc.org/index.php?title=Alopecia_causes&oldid=1702112"